Anandamide exerts its antiproliferative actions on cholangiocarcinoma by activation of the GPR55 receptor
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anandamide exerts its antiproliferative actions on cholangiocarcinoma by activation of the GPR55 receptor
Authors
Keywords
-
Journal
LABORATORY INVESTIGATION
Volume 91, Issue 7, Pages 1007-1017
Publisher
Springer Nature
Online
2011-04-04
DOI
10.1038/labinvest.2011.62
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A role for L-α-lysophosphatidylinositol and GPR55 in the modulation of migration, orientation and polarization of human breast cancer cells
- (2010) Lesley A Ford et al. BRITISH JOURNAL OF PHARMACOLOGY
- Opposing actions of endocannabinoids on cholangiocarcinoma growth is via the differential activation of Notch signaling
- (2010) Gabriel Frampton et al. EXPERIMENTAL CELL RESEARCH
- Lipid rafts, death receptors and CASMERs: new insights for cancer therapy
- (2010) Faustino Mollinedo et al. Future Oncology
- Lipid rafts and clusters of apoptotic signaling molecule-enriched rafts in cancer therapy
- (2010) Faustino Mollinedo et al. Future Oncology
- Resveratrol enhances the sensitivity of cholangiocarcinoma to chemotherapeutic agents
- (2010) Gabriel A Frampton et al. LABORATORY INVESTIGATION
- The orphan G protein-coupled receptor GPR55 promotes cancer cell proliferation via ERK
- (2010) C Andradas et al. ONCOGENE
- The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation
- (2010) R Piñeiro et al. ONCOGENE
- Pharmacological characterization of GPR55, a putative cannabinoid receptor
- (2010) Haleli Sharir et al. PHARMACOLOGY & THERAPEUTICS
- The endocannabinoid anandamide inhibits cholangiocarcinoma growth via activation of the noncanonical Wnt signaling pathway
- (2008) Sharon DeMorrow et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Serotonin Metabolism Is Dysregulated in Cholangiocarcinoma, which Has Implications for Tumor Growth
- (2008) G. Alpini et al. CANCER RESEARCH
- Cholangiocarcinoma
- (2008) Boris R.A. Blechacz et al. Clinics in Liver Disease
- Integrin clustering enables anandamide-induced Ca2+ signaling in endothelial cells via GPR55 by protection against CB1-receptor-triggered repression
- (2008) M. Waldeck-Weiermair et al. JOURNAL OF CELL SCIENCE
- Effects of sulindac sulfide on the membrane architecture and the activity of γ-secretase
- (2008) Martin Gamerdinger et al. NEUROPHARMACOLOGY
- GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current
- (2008) J. E. Lauckner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects
- (2007) D G Johns et al. BRITISH JOURNAL OF PHARMACOLOGY
- The orphan receptor GPR55 is a novel cannabinoid receptor
- (2007) E Ryberg et al. BRITISH JOURNAL OF PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More